影像、檢驗及病理科系

分子病理科的依據指引

14 個學習主題共依據 26 份臨床指引與文獻。點主題名稱看它的學習重點。

腫瘤基因突變檢測1 份

  1. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of SEAP and SEOM|SEAP + SEOM|2022
    Isla D, Lozano MD, Paz-Ares L, et al. · DOI · CC BY 4.0

次世代定序腫瘤基因套組1 份

  1. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of AMP, ASCO and CAP|AMP + ASCO + CAP|2017
    ASCO的全部指引 · Li MM, Datto M, Duncavage EJ, et al. · DOI

螢光原位雜交判讀2 份

  1. Updated UK Recommendations for HER2 assessment in breast cancer|Journal of Clinical Pathology|2014
    Rakha EA, Pinder SE, Bartlett JMS, et al. · DOI · CC BY-NC
  2. Guidelines for cytogenetic investigations in tumours|UK NCC-BC/UK NEQAS/ECA|2016

免疫組織化學生物標記判讀2 份

  1. HER2 Testing in Breast Cancer: ASCO/CAP Clinical Practice Guideline Focused Update|ASCO + CAP|2018
  2. PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics|Diagnostic Pathology|2018
    Udall M, Rizzo M, Kenny J, et al. · DOI · CC0 1.0

微衛星不穩定性與錯誤配對修復檢測2 份

  1. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer|Archives of Pathology & Laboratory Medicine|2022
    Bartley AN, Mills AM, Konnick E, et al. · DOI
  2. EMQN best practice guidelines for analysis and reporting of microsatellite instability in solid tumours|European Journal of Human Genetics|2025
    Gallon R, McCormick L, Saetta A, et al. · DOI · CC BY 4.0

液態切片與循環腫瘤DNA2 份

  1. Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays|Annals of Laboratory Medicine|2024
    Lee JS, Cho EH, Kim B, et al. · DOI · CC BY-NC 4.0
  2. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology|Clinical and Translational Oncology|2019
    Remon J, García-Campelo R, de Álava E, et al. · DOI · CC BY 4.0

融合基因與染色體轉位偵測2 份

  1. Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing|Current Oncology|2023
    Stockley TL, Lo B, Box A, et al. · DOI · CC BY 4.0
  2. Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing|Journal of Clinical Pathology|2021
    Conde E, Rojo F, Gómez J, et al. · DOI · CC BY-NC 4.0

腫瘤突變負荷量分析2 份

  1. Expert consensus on the detection and clinical application of tumor mutational burden|Cancer Biology & Medicine|2026
    Guo Z, Xu C, Zhang S, et al. · DOI · CC BY-NC
  2. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project|Journal for ImmunoTherapy of Cancer|2020
    Merino DM, McShane LM, Fabrizio D, et al. · DOI · CC BY-NC 4.0

標靶治療伴隨式診斷2 份

  1. Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group of Oncology Therapeutic Products|US FDA|2020
    美國聯邦政府作品(公眾領域)
  2. In Vitro Companion Diagnostic Devices — Guidance for Industry and FDA Staff|US FDA|2014
    美國聯邦政府作品(公眾領域)

血液腫瘤分子分型與微量殘存病灶2 份

  1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN|Blood|2022
    Döhner H, Wei AH, Appelbaum FR, et al. · DOI · CC BY-NC-ND 4.0
  2. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma|Leukemia|2017
    Flores-Montero J, Sanoja-Flores L, Paiva B, et al. · DOI · CC BY-NC-ND 4.0

分子檢測品質管制與驗證2 份

  1. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies|Annals of Laboratory Medicine|2019
    Kim H, Yun JW, Lee ST, et al. · DOI · CC BY-NC 4.0
  2. Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels|The Journal of Molecular Diagnostics|2017
    Jennings LJ, Arcila ME, Corless C, et al. · DOI

檢測報告臨床詮釋與分子腫瘤委員會2 份

  1. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)|Annals of Oncology|2018
    Mateo J, Chakravarty D, Dienstmann R, et al. · DOI
  2. Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group|Cancer Research and Treatment|2022
    Yoon S, Kim M, Hong YS, et al. · DOI · CC BY-NC 3.0

定量聚合酶連鎖反應技術原理2 份

  1. The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020|Clinical Chemistry|2020
    The dMIQE Group, Whale AS, De Spiegelaere W, et al. · DOI · CC BY 4.0
  2. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments|Clinical Chemistry|2009
    Bustin SA, Benes V, Garson JA, et al. · DOI

石蠟包埋檢體核酸萃取與品質評估2 份

  1. Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples|International Journal of Molecular Sciences|2016
    Arreaza G, Qiu P, Pang L, et al. · DOI · CC BY 4.0
  2. Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion|Journal of Histochemistry & Cytochemistry|2020
    Mathieson W, Thomas GA · DOI · CC BY-NC 4.0

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入